P Ardouin

976 total citations
19 papers, 799 citations indexed

About

P Ardouin is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, P Ardouin has authored 19 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in P Ardouin's work include Cancer, Hypoxia, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Treatment and Pharmacology (4 papers). P Ardouin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Treatment and Pharmacology (4 papers). P Ardouin collaborates with scholars based in France, Germany and United States. P Ardouin's co-authors include Ziad Mallat, Alain Tedgui, Bruno Esposito, Stéphane Potteaux, Hervé Groux, Alain Gouyette, Valérie Brun, Olivia van Oostrom, Gilles Vassal and Régine Merval and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer.

In The Last Decade

P Ardouin

19 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Ardouin France 13 341 277 268 131 112 19 799
Gidi Rechavi Israel 17 155 0.5× 265 1.0× 614 2.3× 179 1.4× 113 1.0× 26 1.1k
Yasuji Ishimaru Japan 14 114 0.3× 241 0.9× 346 1.3× 92 0.7× 222 2.0× 45 1.1k
Y. Terui Japan 14 221 0.6× 208 0.8× 330 1.2× 29 0.2× 50 0.4× 29 687
Roger Mouawad France 21 208 0.6× 308 1.1× 523 2.0× 56 0.4× 177 1.6× 57 968
María Villalba Spain 20 341 1.0× 366 1.3× 407 1.5× 39 0.3× 232 2.1× 35 959
Jean‐Claude Pector Belgium 9 373 1.1× 338 1.2× 338 1.3× 28 0.2× 41 0.4× 12 852
Tetsuji Sawada Japan 20 220 0.6× 392 1.4× 494 1.8× 56 0.4× 199 1.8× 38 928
Yozo Kawano Japan 19 124 0.4× 435 1.6× 657 2.5× 33 0.3× 362 3.2× 28 1.2k
Paul Perrotte Canada 7 112 0.3× 216 0.8× 284 1.1× 29 0.2× 179 1.6× 12 552
Adrian Zumsteg Switzerland 11 291 0.9× 271 1.0× 287 1.1× 43 0.3× 89 0.8× 14 803

Countries citing papers authored by P Ardouin

Since Specialization
Citations

This map shows the geographic impact of P Ardouin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Ardouin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Ardouin more than expected).

Fields of papers citing papers by P Ardouin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Ardouin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Ardouin. The network helps show where P Ardouin may publish in the future.

Co-authorship network of co-authors of P Ardouin

This figure shows the co-authorship network connecting the top 25 collaborators of P Ardouin. A scholar is included among the top collaborators of P Ardouin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Ardouin. P Ardouin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Magnon, Claire, Paule Opolon, Marcel Ricard, et al.. (2007). Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1α–mediated tumor apoptotic switch. Journal of Clinical Investigation. 117(7). 1844–1855. 55 indexed citations
2.
Potteaux, Stéphane, Christophe Combadière, Bruno Esposito, et al.. (2006). Role of Bone Marrow–Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology. 26(8). 1858–1863. 88 indexed citations
3.
Potteaux, Stéphane, Christophe Combadière, Bruno Esposito, et al.. (2005). Chemokine Receptor CCR1 Disruption in Bone Marrow Cells Enhances Atherosclerotic Lesion Development and Inflammation in Mice. Molecular Medicine. 11(1-12). 16–20. 49 indexed citations
4.
Schartz, Noël E.C., Nathalie Chaput, Julien Taı̈eb, et al.. (2005). IL‐2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes. European Journal of Immunology. 35(10). 2840–2850. 11 indexed citations
5.
Potteaux, Stéphane, Bruno Esposito, Olivia van Oostrom, et al.. (2004). Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology. 24(8). 1474–1478. 138 indexed citations
6.
Džodić, Radan, Gonzalo Gomez-Abuin, Philippe Rougier, et al.. (2004). Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model. Anti-Cancer Drugs. 15(6). 647–650. 70 indexed citations
7.
Gojová, Andrea, Valérie Brun, Bruno Esposito, et al.. (2003). Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood. 102(12). 4052–4058. 117 indexed citations
8.
Angevin, Eric, A Chassevent, J Bougaran, et al.. (1999). Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosis.. PubMed. 79(7). 879–88. 24 indexed citations
9.
Vassal, Gilles, Corinne Pondarré, Carlo Cappelli, et al.. (1997). DNA-Topoisomerase I, a new target for the treatment of neuroblastoma. European Journal of Cancer. 33(12). 2011–2015. 40 indexed citations
10.
Rougier, Philippe, C Bognel, Radan Džodić, et al.. (1996). Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbits. Cancer Chemotherapy and Pharmacology. 37(4). 371–376. 24 indexed citations
11.
Vassal, Gilles, Jean Bénard, Jackie Morizet, et al.. (1996). Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts. British Journal of Cancer. 74(4). 537–545. 89 indexed citations
12.
Vassal, Gilles, Marie‐José Terrier‐Lacombe, Arielle Lellouch‐Tubiana, et al.. (1996). Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children. International Journal of Cancer. 69(2). 146–151. 16 indexed citations
13.
Vassal, Gilles, Marie‐José Terrier‐Lacombe, Arielle Lellouch‐Tubiana, et al.. (1996). Tumorigenicity of cerebellar primitive neuro‐ectodermal tumors in athymic mice correlates with poor prognosis in children. International Journal of Cancer. 69(2). 146–151. 1 indexed citations
14.
Munck, Jean‐Nicolas, C Bognel, Marcel Ricard, et al.. (1994). Verapamil-reversing concentrations induce blood flow changes that could counteract in vivo the MDR-1-modulating effects. Cancer. 74(3). 810–816. 2 indexed citations
15.
Munck, J. N., C Bognel, Zengren Zhao, et al.. (1993). Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases. British Journal of Cancer. 68(2). 277–281. 12 indexed citations
16.
Munck, J. N., M Riggi, P Rougier, et al.. (1993). Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.. PubMed. 53(7). 1550–4. 38 indexed citations
17.
Gosse, Charlie, Ghanem Atassi, Yves Letourneux, et al.. (1989). Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).. PubMed. 8(6). 1419–22. 3 indexed citations
18.
Lespinasse, Françoise, M. Fatôme, P Ardouin, et al.. (1985). Radioprotection of EMT6 tumor by a new class of radioprotectors based on a pseudo-peptide cysteamine combination. International Journal of Radiation Oncology*Biology*Physics. 11(5). 1035–1038. 15 indexed citations
19.
Dhondt, Jean‐Louis, J. P. Farriaux, C Largillière, M Dautrevaux, & P Ardouin. (1981). Pterin metabolism in normal subjects and hyperphenylalaninaemic patients. Journal of Inherited Metabolic Disease. 4(1). 47–48. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gidi Rechavi Breakdown of academic impact, for papers by Yasuji Ishimaru Breakdown of academic impact, for papers by Y. Terui Breakdown of academic impact, for papers by Roger Mouawad Breakdown of academic impact, for papers by María Villalba Breakdown of academic impact, for papers by Jean‐Claude Pector Breakdown of academic impact, for papers by Tetsuji Sawada Breakdown of academic impact, for papers by Yozo Kawano Breakdown of academic impact, for papers by Paul Perrotte Breakdown of academic impact, for papers by Adrian Zumsteg
Rankless by CCL
2026